2079896-25-4 GSK4027 GSK 4027;GSK-4027 BCP25140 CAS 2079896-25-4
| CAS No. | 2079896-25-4 |
| Molecular Formula | C17H21BrN4O |
| Molecular Weight | 377.28 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO manufactures 2079896-25-4 GSK4027 GSK 4027;GSK-4027 BCP25140 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
2079896-25-4 GSK4027 GSK 4027;GSK-4027 BCP25140 (CAS 2079896-25-4) is a high-purity analytical reference standard with the molecular formula C17H21BrN4O and a molecular weight of 377.28 g/mol.
Structurally, 2079896-25-4 GSK4027 GSK 4027;GSK-4027 BCP25140 (C17H21BrN4O) contains a steroid core, an amide group, a hydroxyl group, an ether linkage, bromine substitution. The molecule exhibits a degree of unsaturation (DBE) of 9.0, corresponding to approximately 9 ring(s) or double-bond equivalent(s). With a molecular weight of 377.28 g/mol, it falls into the moderately-high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
Physical & Chemical Properties
| Molecular Formula | C17H21BrN4O |
| Molecular Weight | 377.28 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 9.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1997 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 4 |
Recommended Standards
- 2079886-19-2 GSK4028 (CAS 2079886-19-2)
- tert-Butyl (3R)-3-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate (CAS 1138820-79-7)
- tert-Butyl(3-((4-bromophenyl)amino)benzyl)carbamate (CAS 886362-63-6)
- N-(2-(2-Fluorophenoxy)pyrimidin-5-yl)-2-(trifluoromethyl)benzamide (CAS 1396810-05-1)
- 1-(2-(Methylselanyl)-3-phenylcyclobut-2-en-1-yl)ethanone (CAS 820963-05-1)
- (11BS)-2,6-bis(3,5-di-tert-butylphenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide (CAS 1442645-05-7)
- 2,2-Dimethyl-N-[(1S)-2,2,2-trifluoro-1-(1-methyl-1H-indol-3-yl)ethyl]propanamide (CAS 1965314-47-9)
- 4-(4-methyl-1-piperazinyl)-1-butanol 4-(4-methylpiperazin-1-yl)butan-1-ol 56323-03-6 A831000 (CAS 56323-03-6)
- 5-(Methoxycarbonyl)thiophene-2-boronic Acid Pinacol Ester (CAS 916138-13-1)
- Ethyl 3-(2-chloro-4-fluorobenzamido)propanoate (CAS 1241597-46-5)
- 1,3-Dihydroxy-12h-benzo[b]xanthen-12-one (CAS 22315-94-2)
- 1-(Thiophen-2-ylmethyl)cyclopropan-1-ol (CAS 1250060-61-7)
- 4,5-Dihydro-3h-spiro[benzo[b][1,4]oxazepine-2,4'-piperidine] (CAS 867021-92-9)
- Semaglutide impurity 88 (CAS CATO-C4X-222688)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com